Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis

J. Krämer, C. Balloff, M. Weise, V. Koska, Y. Uthmeier, I. Esderts, M. Nguyen-Minh, M. Zimmerhof, A. Hartmann, M. Dietrich, J. Ingwersen, JI. Lee, J. Havla, T. Kümpfel, M. Kerschensteiner, V. Häußler, C. Heesen, JP. Stellmann, HG. Zimmermann, FC....

. 2024 ; 15 (1) : 5243. [pub] 20240619

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013482

Retinal optical coherence tomography has been identified as biomarker for disease progression in relapsing-remitting multiple sclerosis (RRMS), while the dynamics of retinal atrophy in progressive MS are less clear. We investigated retinal layer thickness changes in RRMS, primary and secondary progressive MS (PPMS, SPMS), and their prognostic value for disease activity. Here, we analyzed 2651 OCT measurements of 195 RRMS, 87 SPMS, 125 PPMS patients, and 98 controls from five German MS centers after quality control. Peripapillary and macular retinal nerve fiber layer (pRNFL, mRNFL) thickness predicted future relapses in all MS and RRMS patients while mRNFL and ganglion cell-inner plexiform layer (GCIPL) thickness predicted future MRI activity in RRMS (mRNFL, GCIPL) and PPMS (GCIPL). mRNFL thickness predicted future disability progression in PPMS. However, thickness change rates were subject to considerable amounts of measurement variability. In conclusion, retinal degeneration, most pronounced of pRNFL and GCIPL, occurs in all subtypes. Using the current state of technology, longitudinal assessments of retinal thickness may not be suitable on a single patient level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013482
003      
CZ-PrNML
005      
20240905134235.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-024-49309-7 $2 doi
035    __
$a (PubMed)38897994
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Krämer, Julia $u Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. julia.kraemer@ukmuenster.de $1 https://orcid.org/0000000322195593
245    10
$a Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis / $c J. Krämer, C. Balloff, M. Weise, V. Koska, Y. Uthmeier, I. Esderts, M. Nguyen-Minh, M. Zimmerhof, A. Hartmann, M. Dietrich, J. Ingwersen, JI. Lee, J. Havla, T. Kümpfel, M. Kerschensteiner, V. Häußler, C. Heesen, JP. Stellmann, HG. Zimmermann, FC. Oertel, M. Ringelstein, AU. Brandt, F. Paul, O. Aktas, HP. Hartung, H. Wiendl, SG. Meuth, P. Albrecht
520    9_
$a Retinal optical coherence tomography has been identified as biomarker for disease progression in relapsing-remitting multiple sclerosis (RRMS), while the dynamics of retinal atrophy in progressive MS are less clear. We investigated retinal layer thickness changes in RRMS, primary and secondary progressive MS (PPMS, SPMS), and their prognostic value for disease activity. Here, we analyzed 2651 OCT measurements of 195 RRMS, 87 SPMS, 125 PPMS patients, and 98 controls from five German MS centers after quality control. Peripapillary and macular retinal nerve fiber layer (pRNFL, mRNFL) thickness predicted future relapses in all MS and RRMS patients while mRNFL and ganglion cell-inner plexiform layer (GCIPL) thickness predicted future MRI activity in RRMS (mRNFL, GCIPL) and PPMS (GCIPL). mRNFL thickness predicted future disability progression in PPMS. However, thickness change rates were subject to considerable amounts of measurement variability. In conclusion, retinal degeneration, most pronounced of pRNFL and GCIPL, occurs in all subtypes. Using the current state of technology, longitudinal assessments of retinal thickness may not be suitable on a single patient level.
650    _2
$a lidé $7 D006801
650    12
$a degenerace retiny $x diagnostické zobrazování $x patologie $7 D012162
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a optická koherentní tomografie $x metody $7 D041623
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    12
$a progrese nemoci $7 D018450
650    12
$a relabující-remitující roztroušená skleróza $x diagnostické zobrazování $x patologie $x patofyziologie $7 D020529
650    12
$a retina $x diagnostické zobrazování $x patologie $7 D012160
650    12
$a chronicko-progresivní roztroušená skleróza $x diagnostické zobrazování $x patologie $x patofyziologie $7 D020528
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a prognóza $7 D011379
650    _2
$a nervová vlákna $x patologie $7 D009412
650    _2
$a retinální gangliové buňky $x patologie $7 D012165
655    _2
$a časopisecké články $7 D016428
700    1_
$a Balloff, Carolin $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany $u Department of Neurology, Kliniken Maria Hilf, Mönchengladbach, Germany
700    1_
$a Weise, Margit $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Koska, Valeria $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Uthmeier, Yannik $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Esderts, Isabell $u Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany
700    1_
$a Nguyen-Minh, Mai $u Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany
700    1_
$a Zimmerhof, Moritz $u Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany
700    1_
$a Hartmann, Alex $u Hanseatic Statistics, Hamburg, Germany $1 https://orcid.org/0000000262423047
700    1_
$a Dietrich, Michael $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Ingwersen, Jens $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Lee, John-Ih $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Havla, Joachim $u Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany
700    1_
$a Kümpfel, Tania $u Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany
700    1_
$a Kerschensteiner, Martin $u Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany $u Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University München, München, Germany $u Munich Cluster for Systems Neurology (SyNergy), Munich, Germany $1 https://orcid.org/0000000348989383
700    1_
$a Häußler, Vivien $u Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany $u Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Heesen, Christoph $u Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany $u Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Stellmann, Jan-Patrick $u Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany $u Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany $u Aix-Marseille University, CNRS-CRMBM, UMR, 7339, Marseille, France $u APHM La Timone, CEMEREM, Marseille, France
700    1_
$a Zimmermann, Hanna G $u Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Oertel, Frederike C $u Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Ringelstein, Marius $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany $u Department of Neurology, Center for Neurology and Neuropsychiatry, LVR-Klinikum, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany $1 https://orcid.org/0000000336188407
700    1_
$a Brandt, Alexander U $u Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Paul, Friedemann $u Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Aktas, Orhan $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Hartung, Hans-Peter $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany $u Brain and Mind Center, University of Sydney, Sydney, NSW, Australia $u Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Wiendl, Heinz $u Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany $1 https://orcid.org/0000000343103432
700    1_
$a Meuth, Sven G $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
700    1_
$a Albrecht, Philipp $u Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. phil.albrecht@gmail.com $u Department of Neurology, Kliniken Maria Hilf, Mönchengladbach, Germany. phil.albrecht@gmail.com $1 https://orcid.org/000000017987658X
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 15, č. 1 (2024), s. 5243
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38897994 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134229 $b ABA008
999    __
$a ok $b bmc $g 2143352 $s 1225348
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c 1 $d 5243 $e 20240619 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace